Showing 9,201 - 9,220 results of 226,904 for search '(( a ((we decrease) OR (a decrease)) ) OR ( i ((largest decrease) OR (larger decrease)) ))', query time: 1.65s Refine Results
  1. 9201
  2. 9202
  3. 9203
  4. 9204
  5. 9205
  6. 9206
  7. 9207
  8. 9208
  9. 9209
  10. 9210
  11. 9211
  12. 9212
  13. 9213
  14. 9214
  15. 9215

    The abundance of core fucosylation and bisecting modification in N-glycan and glycoprotein levels. by Jie Chen (5892)

    Published 2015
    “…<p>The abundance of core fucosylation and bisecting modification in N-glycan and glycoprotein levels were illustrated using DSA-FACE and serum lectin blot. (A) and (B): The abundance of total core fucosylation residues (the sum of Peak1, 2, 3, 4, 6, 7 and Peak10) from DSA-FACE decreased in LCMM patients (n = 42) than that in healthy controls (n = 42), and decreased according to the severity of the disease [moderate LCMM (n = 14) and severe LCMM (n = 28)]. …”
  16. 9216
  17. 9217

    <i>Caenorhabditis elegans</i> muscle Cys-loop receptors as novel targets of terpenoids with potential anthelmintic activity by Guillermina Hernando (553795)

    Published 2019
    “…To decipher the mechanism by which terpenoids affect these receptors, we performed electrophysiological studies using a primary culture of <i>C</i>. …”
  18. 9218

    RNA Polymerase III Output Is Functionally Linked to tRNA Dimethyl-G26 Modification by Aneeshkumar G. Arimbasseri (840654)

    Published 2015
    “…Extending this more broadly, we show that a decrease in tRNA synthesis by treatment with rapamycin leads to increased m<sup><b>2</b></sup><sub><b>2</b></sub>G26 modification and that this response is conserved among highly divergent yeasts and human cells.…”
  19. 9219
  20. 9220

    Peak3 and Peak7 could be used as diagnosis and differential diagnosis markers for LCMM. by Jie Chen (5892)

    Published 2015
    “…Peak3 and Peak7 were decreased in LCMM group compared with the other 3 groups, except that Peak 3 was elevated in patients with LCMM relative to patients with IgA MM. …”